Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HLA-B Antigens | 16 | 1998 | 331 | 0.710 |
Why?
|
Receptor, Notch1 | 6 | 2014 | 495 | 0.710 |
Why?
|
Receptors, Notch | 4 | 2017 | 742 | 0.500 |
Why?
|
Genes, MHC Class I | 7 | 1996 | 240 | 0.490 |
Why?
|
Electrophoretic Mobility Shift Assay | 2 | 2014 | 295 | 0.460 |
Why?
|
Policy | 1 | 2016 | 511 | 0.410 |
Why?
|
HLA-A Antigens | 7 | 1997 | 225 | 0.370 |
Why?
|
Documentation | 1 | 2016 | 892 | 0.350 |
Why?
|
Immunoglobulin J Recombination Signal Sequence-Binding Protein | 4 | 2014 | 121 | 0.320 |
Why?
|
Advance Care Planning | 1 | 2016 | 697 | 0.320 |
Why?
|
Gene Expression Regulation, Leukemic | 3 | 2017 | 645 | 0.280 |
Why?
|
Alleles | 17 | 1997 | 6900 | 0.260 |
Why?
|
Patient Care Team | 1 | 2016 | 2510 | 0.250 |
Why?
|
Immunoglobulin Fragments | 1 | 2004 | 85 | 0.240 |
Why?
|
Sequence Homology, Nucleic Acid | 6 | 2014 | 1056 | 0.230 |
Why?
|
Enhancer Elements, Genetic | 3 | 2017 | 1356 | 0.230 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2017 | 381 | 0.220 |
Why?
|
Promoter Regions, Genetic | 4 | 2017 | 5784 | 0.210 |
Why?
|
DNA | 6 | 2014 | 7236 | 0.200 |
Why?
|
Epitopes | 4 | 1997 | 2506 | 0.190 |
Why?
|
Sequence Alignment | 6 | 2014 | 2178 | 0.180 |
Why?
|
Molecular Sequence Data | 20 | 2014 | 17628 | 0.170 |
Why?
|
Base Sequence | 17 | 2014 | 12447 | 0.170 |
Why?
|
Electronic Health Records | 1 | 2016 | 4763 | 0.160 |
Why?
|
HLA-B7 Antigen | 2 | 1995 | 50 | 0.160 |
Why?
|
Dimerization | 2 | 2010 | 890 | 0.130 |
Why?
|
HLA-B8 Antigen | 1 | 1995 | 18 | 0.130 |
Why?
|
HLA-A2 Antigen | 1 | 1996 | 211 | 0.130 |
Why?
|
Models, Molecular | 5 | 2014 | 5429 | 0.120 |
Why?
|
Inservice Training | 1 | 2016 | 376 | 0.110 |
Why?
|
Professional Role | 1 | 2016 | 311 | 0.110 |
Why?
|
Multiprotein Complexes | 2 | 2013 | 1120 | 0.110 |
Why?
|
Genes, myc | 1 | 2014 | 395 | 0.110 |
Why?
|
Crystallography, X-Ray | 2 | 2010 | 1979 | 0.110 |
Why?
|
HLA Antigens | 2 | 1995 | 1369 | 0.100 |
Why?
|
Histocompatibility Antigens Class I | 2 | 1996 | 1354 | 0.100 |
Why?
|
T-Lymphocytes | 3 | 2011 | 10183 | 0.100 |
Why?
|
Signal Transduction | 7 | 2017 | 23363 | 0.100 |
Why?
|
Workflow | 1 | 2016 | 851 | 0.100 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2011 | 67 | 0.100 |
Why?
|
Genome, Human | 2 | 2017 | 4416 | 0.100 |
Why?
|
Receptor, Notch2 | 1 | 2011 | 87 | 0.090 |
Why?
|
Leukemia, T-Cell | 1 | 2011 | 101 | 0.090 |
Why?
|
Neoplasm Proteins | 2 | 2014 | 3613 | 0.090 |
Why?
|
Environment | 1 | 2016 | 1118 | 0.090 |
Why?
|
Response Elements | 1 | 2011 | 308 | 0.090 |
Why?
|
Tumor Cells, Cultured | 4 | 2017 | 6131 | 0.080 |
Why?
|
Transcription, Genetic | 5 | 2014 | 7593 | 0.080 |
Why?
|
Amino Acid Sequence | 10 | 1998 | 13456 | 0.080 |
Why?
|
Histocompatibility Testing | 5 | 1997 | 717 | 0.080 |
Why?
|
Binding Sites | 3 | 2013 | 6050 | 0.080 |
Why?
|
Polymorphism, Genetic | 2 | 1997 | 4286 | 0.070 |
Why?
|
Protein Structure, Tertiary | 3 | 2010 | 3800 | 0.070 |
Why?
|
Conserved Sequence | 1 | 2010 | 1168 | 0.070 |
Why?
|
Cell Nucleus | 2 | 2014 | 2909 | 0.070 |
Why?
|
Residence Characteristics | 1 | 2016 | 2058 | 0.070 |
Why?
|
Patient Education as Topic | 1 | 2016 | 2311 | 0.070 |
Why?
|
Transcription Factors | 3 | 2017 | 12100 | 0.070 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 2 | 2010 | 801 | 0.060 |
Why?
|
Protein Binding | 2 | 2017 | 9336 | 0.060 |
Why?
|
Protein Multimerization | 1 | 2010 | 983 | 0.060 |
Why?
|
Cell Line | 10 | 1998 | 15626 | 0.060 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2010 | 1137 | 0.060 |
Why?
|
Cell Communication | 1 | 2011 | 1642 | 0.060 |
Why?
|
Static Electricity | 1 | 2004 | 261 | 0.060 |
Why?
|
Protein Structure, Quaternary | 1 | 2004 | 428 | 0.060 |
Why?
|
HLA-C Antigens | 4 | 1997 | 147 | 0.060 |
Why?
|
Cell Lineage | 1 | 2011 | 2525 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2016 | 3870 | 0.050 |
Why?
|
Communication | 1 | 2016 | 3846 | 0.050 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2014 | 859 | 0.050 |
Why?
|
Escherichia coli | 1 | 2014 | 4223 | 0.050 |
Why?
|
Homeodomain Proteins | 1 | 2010 | 2414 | 0.050 |
Why?
|
Gene Expression | 1 | 2014 | 7592 | 0.050 |
Why?
|
Protein Folding | 1 | 2004 | 867 | 0.050 |
Why?
|
Cell Line, Transformed | 3 | 1995 | 871 | 0.040 |
Why?
|
Repressor Proteins | 1 | 2010 | 2978 | 0.040 |
Why?
|
Humans | 32 | 2017 | 760261 | 0.040 |
Why?
|
Genetic Variation | 5 | 1997 | 6540 | 0.040 |
Why?
|
Protein Conformation | 2 | 2014 | 3969 | 0.040 |
Why?
|
Indians, South American | 1 | 1997 | 34 | 0.040 |
Why?
|
Sequence Homology, Amino Acid | 3 | 1997 | 2755 | 0.030 |
Why?
|
Animals | 10 | 2017 | 167940 | 0.030 |
Why?
|
Hepatitis C Antigens | 1 | 1996 | 34 | 0.030 |
Why?
|
HLA-DR3 Antigen | 1 | 1995 | 33 | 0.030 |
Why?
|
Cell Line, Tumor | 4 | 2014 | 16905 | 0.030 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2011 | 4024 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 11902 | 0.030 |
Why?
|
HLA-B27 Antigen | 1 | 1995 | 63 | 0.030 |
Why?
|
Pan troglodytes | 1 | 1996 | 224 | 0.030 |
Why?
|
Blood Grouping and Crossmatching | 1 | 1995 | 100 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2016 | 25928 | 0.030 |
Why?
|
Leukemia | 2 | 2010 | 1522 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2004 | 6543 | 0.030 |
Why?
|
Mice | 5 | 2017 | 81216 | 0.030 |
Why?
|
Lectins, C-Type | 1 | 1997 | 591 | 0.030 |
Why?
|
Sequence Analysis, DNA | 3 | 2011 | 4717 | 0.030 |
Why?
|
Peptides | 2 | 1997 | 4358 | 0.030 |
Why?
|
Receptors, Interleukin-7 | 1 | 2013 | 40 | 0.030 |
Why?
|
B-Lymphocytes | 6 | 1996 | 4739 | 0.030 |
Why?
|
Indians, North American | 1 | 1997 | 355 | 0.030 |
Why?
|
Membrane Glycoproteins | 2 | 2010 | 3731 | 0.030 |
Why?
|
DNA-Binding Proteins | 1 | 2010 | 9590 | 0.030 |
Why?
|
Luciferases | 1 | 2013 | 716 | 0.020 |
Why?
|
Skin Neoplasms | 1 | 2011 | 5797 | 0.020 |
Why?
|
Japan | 1 | 1996 | 1369 | 0.020 |
Why?
|
Isoelectric Focusing | 3 | 1996 | 160 | 0.020 |
Why?
|
Receptors, Immunologic | 1 | 1997 | 1434 | 0.020 |
Why?
|
Lod Score | 1 | 2011 | 602 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2014 | 1531 | 0.020 |
Why?
|
Isoantibodies | 1 | 1994 | 661 | 0.020 |
Why?
|
Codon, Nonsense | 1 | 2011 | 282 | 0.020 |
Why?
|
Antigen Presentation | 1 | 1996 | 1254 | 0.020 |
Why?
|
Haplotypes | 1 | 1996 | 2764 | 0.020 |
Why?
|
DNA Primers | 1 | 2013 | 2819 | 0.020 |
Why?
|
Plasmids | 1 | 2013 | 2277 | 0.020 |
Why?
|
DNA, Complementary | 3 | 1997 | 1993 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 1997 | 2204 | 0.020 |
Why?
|
Lymphocytes | 1 | 1996 | 2612 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2011 | 729 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 1996 | 4109 | 0.020 |
Why?
|
Antigens, CD | 1 | 1997 | 4002 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2011 | 13249 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2010 | 995 | 0.020 |
Why?
|
Histones | 1 | 2014 | 2583 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2011 | 2424 | 0.010 |
Why?
|
Genome-Wide Association Study | 2 | 2014 | 12602 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4573 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2014 | 3448 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2011 | 22025 | 0.010 |
Why?
|
Protein Transport | 1 | 2008 | 1966 | 0.010 |
Why?
|
Ligands | 1 | 2008 | 3277 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2017 | 9388 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2010 | 5873 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5793 | 0.010 |
Why?
|
Cell Movement | 1 | 2011 | 5206 | 0.010 |
Why?
|
Chromatin | 1 | 2011 | 2939 | 0.010 |
Why?
|
Stem Cells | 1 | 2011 | 3525 | 0.010 |
Why?
|
Evolution, Molecular | 2 | 1997 | 1884 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1995 | 9196 | 0.010 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily D | 1 | 1997 | 30 | 0.010 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily C | 1 | 1997 | 35 | 0.010 |
Why?
|
Receptors, Natural Killer Cell | 1 | 1997 | 57 | 0.010 |
Why?
|
Isoelectric Point | 1 | 1997 | 76 | 0.010 |
Why?
|
Receptors, KIR | 1 | 1997 | 113 | 0.010 |
Why?
|
Polymerase Chain Reaction | 2 | 1997 | 6067 | 0.010 |
Why?
|
Lectins | 1 | 1997 | 485 | 0.010 |
Why?
|
Blood Donors | 1 | 1997 | 343 | 0.010 |
Why?
|
Thailand | 1 | 1996 | 289 | 0.010 |
Why?
|
Base Composition | 1 | 1995 | 290 | 0.010 |
Why?
|
Africa, Eastern | 1 | 1995 | 76 | 0.010 |
Why?
|
HLA-B35 Antigen | 1 | 1994 | 7 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2010 | 18968 | 0.010 |
Why?
|
Serology | 1 | 1994 | 7 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2010 | 10434 | 0.010 |
Why?
|
Isoantigens | 1 | 1997 | 552 | 0.010 |
Why?
|
Immune Sera | 1 | 1994 | 613 | 0.010 |
Why?
|
Mexican Americans | 1 | 1995 | 165 | 0.010 |
Why?
|
Mexico | 1 | 1995 | 760 | 0.010 |
Why?
|
Antibody Specificity | 1 | 1994 | 1061 | 0.010 |
Why?
|
Cytotoxicity, Immunologic | 1 | 1996 | 1351 | 0.010 |
Why?
|
Species Specificity | 1 | 1996 | 2413 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 1996 | 1526 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 1997 | 3086 | 0.010 |
Why?
|
Reference Standards | 1 | 1994 | 1004 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 1997 | 1828 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1995 | 4172 | 0.010 |
Why?
|
Cysteine | 1 | 1994 | 897 | 0.010 |
Why?
|
Antibodies | 1 | 1997 | 2424 | 0.010 |
Why?
|
Biological Evolution | 1 | 1995 | 1074 | 0.010 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 1996 | 1765 | 0.000 |
Why?
|
Gene Frequency | 1 | 1995 | 3605 | 0.000 |
Why?
|
Pedigree | 1 | 1995 | 4577 | 0.000 |
Why?
|
Male | 2 | 1995 | 359413 | 0.000 |
Why?
|
Female | 2 | 1995 | 391011 | 0.000 |
Why?
|
United States | 1 | 1995 | 72363 | 0.000 |
Why?
|
Child | 1 | 1995 | 79758 | 0.000 |
Why?
|
Concepts
(177)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(6)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_